Venrock Announces Promotion

Venrock said Wednesday that it has promoted David Stepp to partner. Prior to joining Venrock, Stepp worked at Cooley LLP where his practice focused on venture capital partnerships and emerging growth and small-cap public technology companies. Based in Palo Alto, Calif., Venrock is a venture capital firm.


Palo Alto, Calif., July 31, 2013 – Venrock, a pioneering venture capital firm established in 1969 by the Rockefeller family, today announced the promotion of David Stepp to partner. In addition to helping shape firm strategy, Stepp oversees the firm’s operations and administration, including structuring of fundraisings, investor relations, human resources, and the finance and legal functions. Stepp advises portfolio companies and actively participates in the structuring and implementation of portfolio investments, exits and significant transactions. Stepp is also responsible for the regulatory and compliance functions of the firm and serves as chief compliance officer.
“David Stepp has been a key contributor across all dimensions of our business over the last six years,” said Bryan Roberts, partner at Venrock. “David’s promotion is a recognition of his commitment to our firm, its limited partners and our entrepreneurs. He is a terrific colleague and richly deserves this recognition.”
Stepp joined Venrock as general counsel in 2007 from Cooley LLP. At Cooley, his practice focused on the formation and representation of venture capital partnerships and the representation of emerging growth and small-cap public technology companies. Stepp earned his B.S. in Molecular and Cellular Biology from the University of Arizona and his J.D. from Harvard Law School.
About Venrock
Originally established as the venture capital arm of the Rockefeller family in 1969, Venrock continues a tradition of partnering with entrepreneurs to establish successful, enduring companies. With a primary focus on technology and healthcare, portfolio companies have included Adify, Apple Computer, Athenahealth, Centocor, Check Point Software, DoubleClick, Endeca, Gilead Sciences, Idec Pharma, Imperva, Illumina, Intel, Millennium Pharma, SlideShare and Tudou. For more information, please visit Venrock’s website at and follow the firm on Twitter at @venrock.